Vor Bio to Participate in the Stifel 2024 Healthcare Conference

About this update from Vor Biopharma Inc.

CAMBRIDGE, Mass. , Nov. 12, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host 1x1 investor meetings at the Stifel 2024 Healthcare Conference. Stifel 2024 Healthcare Conference Fireside Chat: Monday, November 18, 2024 at 2:25 pm ET Location: New York, NY A live webcast and archived replay of the fireside chat will be available on the investors section of www.vorbio.com . About Vor Bio Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com . Contact: Media & Investors Sarah Spencer +1 857-242-6076 [email protected] Source: Vor Biopharma

View stock analysis, news, and events for Vor Biopharma Inc.